α-Hydroxyetizolam
Clinical data
Other namesα-Hydroxyetizolam
Dependence
liability		Moderate
Routes of
administration		Oral, sublingual, rectal
Pharmacokinetic data
MetabolismHepatic
Elimination half-life8.2 hours[1]
ExcretionKidney
Identifiers
  • 1-[7-(2-chlorophenyl)-13-methyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-4-yl]ethanol
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H15ClN4OS
Molar mass358.84 g·mol−1
3D model (JSmol)
  • CC1=NN=C2N1C3=C(C=C(S3)C(C)O)C(=NC2)C4=CC=CC=C4Cl
  • InChI=1S/C17H15ClN4OS/c1-9(23)14-7-12-16(11-5-3-4-6-13(11)18)19-8-15-21-20-10(2)22(15)17(12)24-14/h3-7,9,23H,8H2,1-2H3
  • Key:YRJXUAYHZCDGDO-UHFFFAOYSA-N

α-Hydroxyetizolam is the pharmacologically active metabolite of etizolam.[2] α-Hydroxyetizolam has a half-life of approximately 8.2 hours.[3]

Etizolam's other non-pharmacologically active metabolite in humans is 8-hydroxyetizolam.[2]

See also

References

  1. ↑ Fracasso C, Confalonieri S, Garattini S, Caccia S (1991-02-01). "Single and multiple dose pharmacokinetics of etizolam in healthy subjects". European Journal of Clinical Pharmacology. 40 (2): 181–185. doi:10.1007/BF00280074. PMID 2065698. S2CID 10176681.
  2. 1 2 "alpha-Hydroxyetizolam". PubChem. U.S. National Library of Medicine. Retrieved 2021-02-23.
  3. ↑ Nakamae T, Shinozuka T, Sasaki C, Ogamo A, Murakami-Hashimoto C, Irie W, et al. (November 2008). "Case report: Etizolam and its major metabolites in two unnatural death cases". Forensic Science International. 182 (1–3): e1-6. doi:10.1016/j.forsciint.2008.08.012. PMID 18976871.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.